Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
avian influenza vaccine
Manufacturing
GSK, Sanofi, CSL nab BARDA funding for bird flu shots
CSL Seqirus, Sanofi and GSK have collectively secured $72 million in BARDA funding to boost U.S. supply of bird flu vaccines.
Angus Liu
Oct 4, 2024 1:35pm
Europe taps CSL Seqirus to produce bird flu vaccines
Jun 11, 2024 4:20pm
CSL Seqirus to trial avian vaccine candidate in $30M BARDA deal
Oct 10, 2022 10:39am
Daiichi Sankyo comes up far short in avian flu vaccine effort
May 22, 2019 10:19am
Secretive Moderna unveils first-in-human data
May 2, 2017 4:29pm
Protein Sciences tasked with developing avian flu vaccines
Mar 21, 2017 2:52pm
